Petros Pharmaceuticals
PTPI
₹6.17
Share price
-14.29%
Change (1 day)
-93.08%
Change (1 year)
Categories
Operating Margin for Petros Pharmaceuticals (PTPI)
Operating Margin as of April 2025 (TTM): -117.52%
According to Petros Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is -117.52%. At the end of 2023 the company had an Operating Margin of -140.20%.
Operating Margin history for Petros Pharmaceuticals from 2020 to 2024
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2023 | -140.20% | -58.07% |
| 2022 | -334.40% | 190.66% |
| 2021 | -115.05% | -50.04% |
| 2020 | -230.27% | 8.18% |
| 2019 | -212.86% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 | 22.85% | -119.44% | 🇺🇸 USA |
 | -234,760.00% | 199,661.74% | Bahamas |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.